Latest Avandia news
CYP2C8, SLCO1B1 Variants Impact Response to Rosiglitazone
posted June 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Genetic variants in CYP2C8 and SLCO1B1 impact the therapeutic response to rosiglitazone in patients with type 2 diabetes, according to a study published online June 6 in Diabetes Care.
Addition of Glitazone to Chemo May Help Treat CML
posted September 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Patients with chronic myeloid leukemia who received a glitazone along with imatinib remained disease-free for up to nearly five years in a study published online Sept. 2 in Nature.
Editor's Recommendations
Cancer-Attributable Costs High for Seniors, Vary With Cancer Phase, Type, Race 
Mental Distress, Fatigue Common in Childhood Survivors of Leukemia, Lymphoma 
Hematologic Cancer Survivors Face Higher Risk of Developing Cardiovascular Disease 
Oral Drug Combo Effective for Older Patients With Acute Myeloid Leukemia Related Articles
Study IDs Dementia Risk Factors in Those Older Than 90 Years 
Achieving PSA <0.2 ng/mL Improves Survival in Metastatic Castration-Sensitive Prostate Cancer 
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Emergency Presentation of Cancer Common in Older Adults Monthly Specialist Briefings
Stay Connected
